Endovenous Radiofrequency Versus Laser Ablation for the Treatment of Great Saphenous Vein Reflux

Prospective, Randomized Study of Endovenous Segmental Radiofrequency Versus 1320 nm Laser Ablation for the Treatment of Great Saphenous Vein Reflux (RVLAb Study)

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02080013

Enrollment

Registered

2014-03-06

Start date

2011-12-31

Completion date

2013-11-30

Last updated

2014-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Varicose Veins

Brief summary

our aim is to compare early outcomes following EVL 1320 nm and segmental RF in a randomized study.

Detailed description

Endovenous Radiofrequency versus Laser Ablation for the Treatment of Great Saphenous Vein Reflux

Interventions

OTHERradiofrequency

ClosureFAST

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 60 Years

Healthy volunteers

Inclusion criteria

* Patients between the ages of 18 and 60 years with incompetent GSVs documented on duplex ultrasound (US; B-mode and color Doppler imaging) were eligible

Exclusion criteria

Design outcomes

Primary

Measure	Time frame
Number of Participants with Adverse Events as a Measure of Safety and Tolerability	30 days

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026